SUBSCRIBE
SUBSCRIBE
News   Business

eGene Inc. Revenue Increases 165 Percent In Second Quarter 2006 Compared To Second Quarter 2005

August 14, 2006 | 
1 min read

eGene Inc. (OTCBB:EGEI), a leading bioengineering company and developer of a compact and automated digital genetic analyzer, announced today its results for the second quarter ending June 30, 2006.

Earnings
MORE ON THIS TOPIC
Pictured: GSK laboratories in Dresden, Germany
Earnings
GSK Looks to Deal in Cancer, Respiratory, Inflammation in 2025
February 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Earnings
Pipeline Problems Mar Amgen’s Q4 Beat
February 5, 2025
 · 
3 min read
 · 
Tristan Manalac
Podcast
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market
February 5, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration of a computer choosing from a display
Opinion
Pharma M&A Uptick Ushers in a New Era of Data Integration
February 5, 2025
 · 
4 min read
 · 
Raj Indupuri